Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Prolonged Molecular and Clinical Remissions in Follicular Lymphoma Patients Treated with HDT/ASCT and Combination Immunotherapy with Rituximab and Interferon α

Liam Smyth, MD FRCPath, Rena Buckstein, MD FRCPC, Pennell Nancy, BSc, Rashmi Weerasinghe, Matthew Cheung, MD MS, FRCP, Eugenia Piliotis, MD FRCP, MD, Kevin Imrie, MD, David Spaner, MD PhD, Marciano D. Reis, MD, Lisa Chodirker, MD, Zeina Ghorab, Violet ruth,nancy Milliken, Angela Boudreau, RN, BScN, MN, CON(C), Neil Berinstein, MD

Blood (2017) 130 (Supplement 1): 4069.

https://doi.org/10.1182/blood.V130.Suppl_1.4069.4069

Published: 2017

Journal Articles

A Phase I Study of Romidepsin, Gemcitabine, Dexamethasone and Cisplatin Combination Therapy in the Treatment of Peripheral T-Cell and Diffuse Large B-Cell Lymphoma: Canadian Cancer Trials Group Study LY.15

Tony Reiman, MD, Kerry J. Savage, MD MSc, Michael Crump, MD, Matthew Cheung, MD, David A. MacDonald, MD, Rena Buckstein, MD, Stephen Couban, MD, Eugenia Piliotis, MD, Kevin R Imrie, MD, David Spaner, MD PhD, Sudeep Shivakumar, MD, John Kuruvilla, MD, Diego Villa, Lois E. Shepherd, MD, Tanya Skamene, MD, Chad Winch, Bingshu E Chen, PhD, Annette E Hay, MB ChB

Blood (2016) 128 (22): 4162.

https://doi.org/10.1182/blood.V128.22.4162.4162

Published: 2016

Journal Articles

The Association of Dyslipidemia with the Development of Chronic Lymphocytic Leukemia: A Population-Based Study

Lee Mozessohn, MD FRCPC, Craig Earle, MD, David Spaner, MD PhD, Stephanie Y. Cheng, MSc, Matthew Kumar, MSc, Rena Buckstein, MD

Blood (2015) 126 (23): 5268.

https://doi.org/10.1182/blood.V126.23.5268.5268

Published: 2015

Journal Articles

A Link Between Hypercholesterolemia and Chronic Lymphocytic Leukemia

Signy Chow, MD FRCPC, Rena Buckstein, MD FRCPC, David Spaner, MD FRCPC, PhD

Blood (2014) 124 (21): 5630.

https://doi.org/10.1182/blood.V124.21.5630.5630

Published: 2014

Journal Articles

Results of a Phase 2 Study of MEDI-551 and Bendamustine Vs Rituximab and Bendamustine in Relapsed or Refractory Chronic Lymphocytic Leukemia

Douglas Gladstone, MD, Marc Andre, MD PhD, Jan Zaucha, MD PhD, Sarit Assouline, MD MSc, Naresh Bellam, MD MPH, Nicole Cascavilla, MD, Eric Jourdan, MD PhD, Amit Panwalkar, MD, Caterina Patti, MD, Clemens Schulte, MD, Francesco Zaja, MD, Trishna Goswami, MD, Nairouz Elgeioushi, MPH, Katie Streicher, PhD, Haifeng Bao, PhD, David Spaner, MD FRCPC, PhD

Blood (2014) 124 (21): 4472.

https://doi.org/10.1182/blood.V124.21.4472.4472

Published: 2014

Journal Articles

Effective Treatment Of Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma With Autologous T Cells Genetically-Engineered To Express An Anti-CD19 Chimeric Antigen Receptor

James N. Kochenderfer, M.D., Mark E. Dudley, Ph.D., Sadik H. Kassim, Ph.D., Robert O. Carpenter, James C. Yang, MD, Giao Q. Phan, MD, Marybeth S. Hughes, MD, Richard M. Sherry, MD, Steven Feldman, Ph.D., David Spaner, MD, PhD, Debbie-Ann N. Nathan, RN, Kathleen E. Morton, RN, Mary Ann Toomey, RN, Steven A. Rosenberg, M.D., Ph.D.

Blood (2013) 122 (21): 168.

https://doi.org/10.1182/blood.V122.21.168.168

Published: 2013

Journal Articles

A Simplified Real-Time PCR Method for the Quantification of Minimal Residual Disease in Follicular Lymphoma.

Nancy Pennell, M.Sc, Anthony Woods, MD, Rena Buckstein, MD, Kevin Imrie, MD, David Spaner, MD, Marciano Reis, MD, Neil Berinstein, MD

Blood (2004) 104 (11): 5203.

https://doi.org/10.1182/blood.V104.11.5203.5203

Published: 2004

Journal Articles

High Dose Therapy / ASCT with Rituximab for In-Vivo Purging and Post-ASCT Consolidation in Relapsed Follicular Lymphoma Achieves Prolonged Clinical and Molecular Remissions.

Anthony C. Woods, MD, Rena Buckstein, MD, Joy Mangel, MD, Kevin Imrie, MD, David Spaner, MD, Michael Crump, MD, Nancy Pennell, B.Sc, Angela Boudreau, M.Sc, Marciano Reis, MD, Neil Berinstein, MD

Blood (2004) 104 (11): 914.

https://doi.org/10.1182/blood.V104.11.914.914

Published: 2004

NARROW

Prolonged Molecular and Clinical Remissions in Follicular Lymphoma Patients Treated with HDT/ASCT and Combination Immunotherapy with Rituximab and Interferon α

A Phase I Study of Romidepsin, Gemcitabine, Dexamethasone and Cisplatin Combination Therapy in the Treatment of Peripheral T-Cell and Diffuse Large B-Cell Lymphoma: Canadian Cancer Trials Group Study LY.15

The Association of Dyslipidemia with the Development of Chronic Lymphocytic Leukemia: A Population-Based Study

A Link Between Hypercholesterolemia and Chronic Lymphocytic Leukemia

Results of a Phase 2 Study of MEDI-551 and Bendamustine Vs Rituximab and Bendamustine in Relapsed or Refractory Chronic Lymphocytic Leukemia

Effective Treatment Of Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma With Autologous T Cells Genetically-Engineered To Express An Anti-CD19 Chimeric Antigen Receptor

A Simplified Real-Time PCR Method for the Quantification of Minimal Residual Disease in Follicular Lymphoma.

High Dose Therapy / ASCT with Rituximab for In-Vivo Purging and Post-ASCT Consolidation in Relapsed Follicular Lymphoma Achieves Prolonged Clinical and Molecular Remissions.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only